1. Home
  2. PHLT vs ALEC Comparison

PHLT vs ALEC Comparison

Compare PHLT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHLT
  • ALEC
  • Stock Information
  • Founded
  • PHLT 1976
  • ALEC 2013
  • Country
  • PHLT United States
  • ALEC United States
  • Employees
  • PHLT N/A
  • ALEC N/A
  • Industry
  • PHLT Other Consumer Services
  • ALEC Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PHLT Consumer Discretionary
  • ALEC Health Care
  • Exchange
  • PHLT Nasdaq
  • ALEC Nasdaq
  • Market Cap
  • PHLT 215.3M
  • ALEC 174.3M
  • IPO Year
  • PHLT N/A
  • ALEC 2019
  • Fundamental
  • Price
  • PHLT $2.36
  • ALEC $1.70
  • Analyst Decision
  • PHLT
  • ALEC Buy
  • Analyst Count
  • PHLT 0
  • ALEC 6
  • Target Price
  • PHLT N/A
  • ALEC $11.75
  • AVG Volume (30 Days)
  • PHLT 154.4K
  • ALEC 652.5K
  • Earning Date
  • PHLT 03-11-2025
  • ALEC 02-25-2025
  • Dividend Yield
  • PHLT N/A
  • ALEC N/A
  • EPS Growth
  • PHLT N/A
  • ALEC N/A
  • EPS
  • PHLT N/A
  • ALEC N/A
  • Revenue
  • PHLT $120,782,000.00
  • ALEC $61,508,000.00
  • Revenue This Year
  • PHLT $9.72
  • ALEC N/A
  • Revenue Next Year
  • PHLT $9.90
  • ALEC $4.98
  • P/E Ratio
  • PHLT N/A
  • ALEC N/A
  • Revenue Growth
  • PHLT 9.39
  • ALEC N/A
  • 52 Week Low
  • PHLT $2.29
  • ALEC $1.59
  • 52 Week High
  • PHLT $4.35
  • ALEC $7.58
  • Technical
  • Relative Strength Index (RSI)
  • PHLT N/A
  • ALEC 35.20
  • Support Level
  • PHLT N/A
  • ALEC $1.62
  • Resistance Level
  • PHLT N/A
  • ALEC $1.78
  • Average True Range (ATR)
  • PHLT 0.00
  • ALEC 0.12
  • MACD
  • PHLT 0.00
  • ALEC 0.03
  • Stochastic Oscillator
  • PHLT 0.00
  • ALEC 14.68

About PHLT Performant Healthcare Inc. Common Stock

Performant Healthcare Inc delivers payment integrity solutions for its healthcare payer clients.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Share on Social Networks: